Investigation of the diagnostic value of CMV DNA positivity in different clinical samples

Year 2025, Volume: 42 Issue: 3, 274 - 278, 30.09.2025

Canberk Çınar , Sedanur Karaahmet , Yeliz Tanrıverdi Çaycı , Demet Gür Vural , Kemal Bilgin , Asuman Bırıncı

Abstract

Cytomegalovirus, a common herpesvirus, is often acquired during childhood or adolescence. After viral DNA integrates into the host, lifelong latency can occur as latent infection in various organs, including the intestines, without causing disease. However, in immunocompromised individuals, primary infection or reactivation of the latent virus can lead to serious illnesses. Histological and serological tests are used for the diagnosis of cytomegalovirus infection. In addition, detecting cytomegalovirus DNA in plasma or biopsy samples via Polymerase Chain Reaction is also important. In this study, a retrospective analysis was conducted on 200 patients whose samples were sent to the Molecular Microbiology Laboratory of Ondokuz Mayıs University Faculty of Medicine for Cytomegalovirüs Polymerase Chain Reaction testing between 2023 and 2025. Patients who had both plasma and tissue samples sent simultaneously were included in the study. Of the tissue samples analyzed, 92.5% were colonoscopy materials obtained from patients diagnosed with inflammatory bowel disease. The number of patients with both plasma and tissue positivity was 42, 30 patients were tissue positive but plasma negative, and 15 patients were plasma positive but tissue negative. In 113 patients, Cytomegalovirus DNA was not detected in both samples. Detection of cytomegalovirus DNA in plasma does not provide sufficient information for the diagnosis of cytomegalovirus infection, which is a tissue-tropic virus. Performing this test on tissue samples with clinical symptoms may provide more valuable diagnostic information.

Keywords

Cytomegalovirüs , Polymerase Chain Reaction , Inflamatory Bowel Diseases , Tissue , Plasma

References

• Keskinkılıç M, Solmaz S, Şeyhanlı A, Appak Ö, Sayıner A, Özsan H, et al. Evaluation of CMV DNA Antigenemia Status in Patients With Allogeneic Bone Marrow Transplant. Journal of Basic and Clinical Health Sciences. 2024;8(2):236-43.
• Zeng J, Jaijyan DK, Yang S, Pei S, Tang Q, Zhu H. Exploring the potential of cytomegalovirus-based vectors: a review. Viruses. 2023;15(10):2043.
• Kahraman Kilbas EP, Ciftci IH, Kilbas I, Toptan H. Seroprevalence of TORCH Viral Agents in Pregnant Women in Turkey: Systematic Review and Meta-Analysis. Pathogens. 2025;14(1):37.
• Bennett EJ, Raphael D, Martin JB. Cytomegalovirus (CMV). Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th Edition. Saunders: 2015, 8: 1738-52.
• Humar A, Mazzulli T, Moussa G, Razonable RR, Paya CV, Pescovitz MD, et al. Clinical utility of cytomegalovirus (CMV) serology testing in high‐risk CMV D+/R− transplant recipients. American Journal of Transplantation. 2005;5(5):1065-70.
• A Ross S, Novak Z, Pati S, B Boppana S. Overview of the diagnosis of cytomegalovirus infection. Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious Disorders). 2011;11(5):466-74.
• Czader M, Post K, Cheng L. Detection of cytomegalovirus infection by quantitative polymerase chain reaction. Hematological Malignancies. 2013:257-71.
• American Academy of Pediatrics. Cytomegalovirus infection. In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, editors. Red Book: 2021 Report of the Committee on Infectious Diseases. Itasca, IL: American Academy of Pediatrics; 2021, p. 294-300.
• Çolak D, SAĞLIK İ, Can Sarinoglu R, Mutlu D, Peker B, Erman Daloglu A, et al. Comparison of two commercial quantitative cytomegalovirus (cmv) polymerase chain reaction tests calibrated by world health organization international cmv standard. Mikrobiyoloji bulteni. 2020;54(2).
• Dioverti MV, Razonable RR. Cytomegalovirus. Diagnostic Microbiology of the Immunocompromised Host. 2016:97- 125.
• Hazır-Konya H, Avkan-Oğuz V, Akpınar H, Sağol Ö, Sayıner A. Investigation of cytomegalovirus in intestinal tissue in a country with high CMV seroprevalence. The Turkish Journal of Gastroenterology. 2021;32(2):123.
• Rahier J-F, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. Journal of Crohn's and Colitis. 2014;8(6):443-68.
• Öztürk TE, Kıyıcı M, Gülten M, Dolar E, Gürel S, Nak SG, et al. Importance of using tissue PCR to diagnose CMV colitis in ulcerative colitis. Dicle Tıp Dergisi. 2023;50(2):203-10.
• Roblin X, Pillet S, Oussalah A, Berthelot P, Del Tedesco E, Phelip J-M, et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Official journal of the American College of Gastroenterology| ACG. 2011;106(11):2001-8.
• Ciccocioppo R. cytomegalovirus infection in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2015;42(1):127-9.
• Mavropoulou E, Ternes K, Mechie N-C, Bremer SCB, Kunsch S, Ellenrieder V, et al. Cytomegalovirus colitis in inflammatory bowel disease and after haematopoietic stem cell transplantation: diagnostic accuracy, predictors, risk factors and disease outcome. BMJ open gastroenterology. 2019;6(1):e000258.
• Kwon J-S, Kim T, Kim S-M, Sung H, Shin S, Kim YH, et al. Comparison of the commercial QuantiFERON-CMV and overlapping peptide-based ELISPOT assays for predicting CMV infection in kidney transplant recipients. Immune network. 2017;17(5):317-25.
• Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, et al. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clinical Infectious Diseases. 2016:ciw668.
• Goetgebuer R, Van Der Woude C, Bakker L, Van Der Eijk A, De Ridder L, De Vries A. The diagnosis and management of CMV colitis in IBD patients shows high practice variation: A national survey among gastroenterologists. Scandinavian Journal of Gastroenterology. 2022;57(11):1321-6.
• Sharma P, Gupta E, Kumar G, Narula B, Singh G, Agarwal R. Performance evaluation of NeuMoDx 96, a random access system for CMV DNA quantitation. Diagnostic Microbiology and Infectious Disease. 2025:116746.
• Boom R, Sol CJ, Schuurman T, Van Breda A, Weel JF, Beld M, et al. Human cytomegalovirus DNA in plasma and serum specimens of renal transplant recipients is highly fragmented. Journal of clinical microbiology. 2002;40(11):4105-13.